Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001617351-19-000006
Filing Date
2019-05-28
Accepted
2019-05-28 12:59:53
Documents
27
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q f10q3.doclepotaapr302019.htm 10-Q 134944
2 EX31.1 lepota_ex31z1.htm EX-31 7049
3 EX32.1 lepota_ex32z1.htm EX-32.1 2596
  Complete submission text file 0001617351-19-000006.txt   860774

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT none-20190430_cal.xml EX-101.CAL 10172
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT none-20190430_def.xml EX-101.DEF 5364
6 XBRL INSTANCE DOCUMENT none-20190430.xml EX-101.INS 53581
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT none-20190430_lab.xml EX-101.LAB 197017
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT none-20190430_pre.xml EX-101.PRE 143985
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT none-20190430.xsd EX-101.SCH 7723
Mailing Address 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address 5348 VEGAS DR. LAS VEGAS NV 89108 (7)918-553-9095
LEPOTA INC (Filer) CIK: 0001617351 (see all company filings)

EIN.: 471549749 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-198808 | Film No.: 19856793
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries